These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2227819)

  • 1. Effect of chronic administration of ursodeoxycholic acid on the ileal absorption of endogenous bile acids in man.
    Marteau P; Chazouilléres O; Myara A; Jian R; Rambaud JC; Poupon R
    Hepatology; 1990 Nov; 12(5):1206-8. PubMed ID: 2227819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ileal absorption of bile acids in patients with chronic cholestasis: SeHCAT test results and effect of ursodeoxycholic acid (UDCA).
    Chazouillères O; Marteau P; Haniche M; Jian R; Poupon R
    Dig Dis Sci; 1996 Dec; 41(12):2417-22. PubMed ID: 9011452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ursodeoxycholic acid treatment on ileal absorption of bile acids in man as determined by the SeHCAT test.
    Eusufzai S; Ericsson S; Cederlund T; Einarsson K; Angelin B
    Gut; 1991 Sep; 32(9):1044-8. PubMed ID: 1916489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal absorption of the bile acid analogue 75Se-homocholic acid-taurine is increased in primary biliary cirrhosis, and reverts to normal during ursodeoxycholic acid administration.
    Lanzini A; De Tavonatti MG; Panarotto B; Scalia S; Mora A; Benini F; Baisini O; Lanzarotto F
    Gut; 2003 Sep; 52(9):1371-5. PubMed ID: 12912872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical application of a selenium (75Se)-labelled bile acid for the investigation of terminal ileal function.
    Nyhlin H; Brydon G; Danielsson A; Westman S
    Hepatogastroenterology; 1984 Aug; 31(4):187-91. PubMed ID: 6479839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olsalazine does not increase the bile acid losses in subjects with a permanent ileostomy.
    Järnerot G; Sandberg-Gertzén H; Tobiasson P; Vikterlöf KJ
    Scand J Gastroenterol; 1988 May; 23(4):489-92. PubMed ID: 3289113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effects of ursodeoxycholic and chenodeoxycholic acid on the small intestinal absorption of bile acids.
    Stiehl A; Raedsch R; Rudolph G
    Gastroenterology; 1990 Feb; 98(2):424-8. PubMed ID: 2295398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ileal excretion of bile acids: comparison with biliary bile composition and effect of ursodeoxycholic acid treatment.
    Stiehl A; Raedsch R; Rudolph G
    Gastroenterology; 1988 May; 94(5 Pt 1):1201-6. PubMed ID: 3350290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal absorption of bile acids: effect of ursodeoxycholic acid treatment.
    Stiehl A
    Ital J Gastroenterol; 1995 May; 27(4):193-5. PubMed ID: 8520037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct measurement of first-pass ileal clearance of a bile acid in humans.
    Galatola G; Jazrawi RP; Bridges C; Joseph AE; Northfield TC
    Gastroenterology; 1991 Apr; 100(4):1100-5. PubMed ID: 2001808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of ileal function by abdominal counting of the retention of a gamma emitting bile acid analogue.
    Thaysen EH; Orholm M; Arnfred T; Carl J; Rødbro P
    Gut; 1982 Oct; 23(10):862-5. PubMed ID: 7117906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of ursodeoxycholic acid, an enterohepatic drug.
    Hofmann AF
    Scand J Gastroenterol Suppl; 1994; 204():1-15. PubMed ID: 7824870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 75SeHCAT retention half-life and fecal content of individual bile acids in patients with chronic diarrheal disorders.
    Scheurlen C; Kruis W; Büll U; Stellaard F; Lang P; Paumgartner G
    Digestion; 1986; 35(2):102-8. PubMed ID: 3770317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ursodeoxycholic acid ingestion after ileal resection. Effect on biliary bile acid and lipid composition.
    LaRusso NF; Thistle JL
    Dig Dis Sci; 1981 Aug; 26(8):705-9. PubMed ID: 7261834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ursodeoxycholic acid administration on bile acid metabolism in patients with early stages of primary biliary cirrhosis.
    Mazzella G; Parini P; Bazzoli F; Villanova N; Festi D; Aldini R; Roda A; Cipolla A; Polimeni C; Tonelli D
    Dig Dis Sci; 1993 May; 38(5):896-902. PubMed ID: 8482188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ursodeoxycholic acid on the kinetics of the major hydrophobic bile acids in health and in chronic cholestatic liver disease.
    Beuers U; Spengler U; Zwiebel FM; Pauletzki J; Fischer S; Paumgartner G
    Hepatology; 1992 Apr; 15(4):603-8. PubMed ID: 1551637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis.
    Batta AK; Salen G; Arora R; Shefer S; Tint GS; Abroon J; Eskreis D; Katz S
    Hepatology; 1989 Oct; 10(4):414-9. PubMed ID: 2777202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cholestyramine on bile acid pattern and synthesis during administration of ursodeoxycholic acid in man.
    Rust C; Sauter GH; Oswald M; Büttner J; Kullak-Ublick GA; Paumgartner G; Beuers U
    Eur J Clin Invest; 2000 Feb; 30(2):135-9. PubMed ID: 10651838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
    LaRusso NF; Thistle JL
    Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphologic changes in livers of hamsters treated with high doses of ursodeoxycholic acid: correlation with bile acids in bile.
    Mamianetti A; Konopka HF; Lago N; Vescina C; Scarlato E; Carducci CN
    Pharmacol Res; 1994; 29(2):187-95. PubMed ID: 8058592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.